Stocks and Investing Stocks and Investing
Tue, May 14, 2024

Graig Suvannavejh Maintained (AMLX) at Hold with Decreased Target to $3 on, May 14th, 2024


Published on 2024-10-28 11:20:28 - WOPRAI, Graig Suvannavejh
  Print publication without navigation


Graig Suvannavejh of Mizuho, Maintained "Amylyx Pharmaceuticals, Inc." (AMLX) at Hold with Decreased Target from $4 to $3 on, May 14th, 2024.

Graig has made no other calls on AMLX in the last 4 months.



There are 6 other peers that have a rating on AMLX. Out of the 6 peers that are also analyzing AMLX, 4 agree with Graig's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Joel Beatty of "Baird" Maintained at Hold with Decreased Target to $3 on, Thursday, April 11th, 2024
  • Marc Goodman of "Leerink Partners" Downgraded from Buy to Hold on, Monday, March 11th, 2024
  • Chris Shibutani of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $4 on, Monday, March 11th, 2024
  • Umer Raffat of "Evercore ISI Group" Downgraded from Buy to Hold on, Friday, March 8th, 2024


These are the ratings of the 2 analyists that currently disagree with Graig


  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $8 on, Friday, May 10th, 2024
  • Neena Bitritto-Garg of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $8 on, Monday, March 11th, 2024
Contributing Sources